Literature DB >> 23727585

Increased uptake by splenic red pulp macrophages contributes to rapid platelet turnover in WASP(-) mice.

Amanda Prislovsky1, Ted S Strom.   

Abstract

Thrombocytopenia caused by rapid platelet consumption contributes to the severe thrombocytopenia of Wiskott-Aldrich syndrome (WAS) and to the milder thrombocytopenia seen in murine WAS. We show that rapid clearance of ¹¹¹In-labeled murine WASP(-) platelets correlates with enhanced splenic uptake. Using platelets labeled with a pH-sensitive fluorescent marker (pHrodo), we quantify normal platelet uptake by red pulp macrophages (RPMs), and demonstrate its enhancement after in vivo opsonization of platelets. The spleens of WASP(-) mice contain an increased number of RPM, and rapid clearance of WASP(-) platelets in WASP(-) mice in turn generates an increased number of pHrodo(+) splenic RPMs. To separately assess the platelet intrinsic and recipient-dependent functions involved in the clearance and splenic phagocyte uptake of WASP(-) platelets, we performed "crossed" pHrodo(+) platelet injection studies (wild type [WT] to WASP(-), WASP(-) to WT). We show that an extrinsic effect of recipient WASP deficiency on the clearance of WASP(-) platelets correlates with increased platelet uptake by RPMs. An intrinsic effect of platelet WASP deficiency on platelet clearance does not, however, correlate with increased total uptake by WT or WASP(-) RPMs. In contrast to other published findings, we find no evidence of a baseline or antibody-induced increase in phosphatidyl serine exposure on WASP(-) platelets. Our findings suggest that an increased number of RPMs in WASP(-) mice contributes significantly to the increased platelet consumption rate in WASP(-) mice. This might explain the consistent efficacy of splenectomy in murine and clinical WAS. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23727585      PMCID: PMC3884558          DOI: 10.1016/j.exphem.2013.05.003

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  21 in total

1.  Platelets from WAS patients show an increased susceptibility to ex vivo phagocytosis.

Authors:  Amanda Prislovsky; Xueying Zeng; Robert A Sokolic; Elizabeth N Garabedian; Praveen Anur; Fabio Candotti; Ted S Strom
Journal:  Platelets       Date:  2012-07-19       Impact factor: 3.862

2.  Nature of the platelet defect in the Wiskott-Aldrich syndrome.

Authors:  M G Baldini
Journal:  Ann N Y Acad Sci       Date:  1972-10-27       Impact factor: 5.691

3.  Wiskott-Aldrich syndrome: qualitative platelet defects and short platelet survival.

Authors:  K A Gröttum; T Hovig; H Holmsen; A F Abrahamsen; M Jeremic; M Seip
Journal:  Br J Haematol       Date:  1969-10       Impact factor: 6.998

Review 4.  Wiskott-Aldrich Syndrome at the nexus of autoimmune and primary immunodeficiency diseases.

Authors:  Sophia Y Cleland; Richard M Siegel
Journal:  FEBS Lett       Date:  2011-10-25       Impact factor: 4.124

5.  The Wiskott-Aldrich syndrome: studies of lymphocytes, granulocytes, and platelets.

Authors:  H D Ochs; S J Slichter; L A Harker; W E Von Behrens; R A Clark; R J Wedgwood
Journal:  Blood       Date:  1980-02       Impact factor: 22.113

6.  Platelet kinetics in patients with bone marrow hypoplasia: evidence for a fixed platelet requirement.

Authors:  S R Hanson; S J Slichter
Journal:  Blood       Date:  1985-11       Impact factor: 22.113

7.  Splenectomy and/or bone marrow transplantation in the management of the Wiskott-Aldrich syndrome: long-term follow-up of 62 cases.

Authors:  C A Mullen; K D Anderson; R M Blaese
Journal:  Blood       Date:  1993-11-15       Impact factor: 22.113

8.  Development and characterization of monoclonal antiplatelet autoantibodies from autoimmune thrombocytopenic purpura-prone (NZW x BXSB)F1 mice.

Authors:  H Mizutani; R W Engelman; Y Kurata; S Ikehara; R A Good
Journal:  Blood       Date:  1993-08-01       Impact factor: 22.113

9.  A numerical analysis model for interpretation of flow cytometric studies of ex vivo phagocytosis.

Authors:  Ted S Strom; Praveen Anur; Amanda Prislovsky
Journal:  PLoS One       Date:  2011-11-04       Impact factor: 3.240

10.  A numerical analysis model for the interpretation of in vivo platelet consumption data.

Authors:  Ted S Strom
Journal:  PLoS One       Date:  2013-01-28       Impact factor: 3.240

View more
  3 in total

1.  Autonomous role of Wiskott-Aldrich syndrome platelet deficiency in inducing autoimmunity and inflammation.

Authors:  Lucia Sereni; Maria Carmina Castiello; Francesco Marangoni; Achille Anselmo; Dario di Silvestre; Sara Motta; Elena Draghici; Stefano Mantero; Adrian J Thrasher; Silvia Giliani; Alessandro Aiuti; Pierluigi Mauri; Luigi D Notarangelo; Marita Bosticardo; Anna Villa
Journal:  J Allergy Clin Immunol       Date:  2018-02-06       Impact factor: 10.793

2.  Thrombocytopenia and splenic platelet-directed immune responses after IV ChAdOx1 nCov-19 administration.

Authors:  Leo Nicolai; Alexander Leunig; Kami Pekayvaz; Max Esefeld; Afra Anjum; Justina Rath; Eva Riedlinger; Vincent Ehreiser; Magdalena Mader; Luke Eivers; Marie-Louise Hoffknecht; Zhe Zhang; Daniela Kugelmann; Dario Rossaro; Raphael Escaig; Rainer Kaiser; Vivien Polewka; Anna Titova; Tobias Petzold; Karsten Spiekermann; Matteo Iannacone; Thomas Thiele; Andreas Greinacher; Konstantin Stark; Steffen Massberg
Journal:  Blood       Date:  2022-08-04       Impact factor: 25.476

Review 3.  Role of Rho-GTPases in megakaryopoiesis.

Authors:  William Vainchenker; Brahim Arkoun; Francesca Basso-Valentina; Larissa Lordier; Najet Debili; Hana Raslova
Journal:  Small GTPases       Date:  2021-02-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.